
Pregabalin (75mg) + Nortriptyline (10mg)
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Medical applications
The New Nervijen-NP Tablet is a combined pharmaceutical formulation designed for the management of neuropathic pain and depressive disorders. Each tablet contains 75mg Pregabalin and 10mg Nortriptyline. Pregabalin, a gabapentinoid, is effective in relieving neuropathic pain by modulating calcium channels, while Nortriptyline, a tricyclic antidepressant, is primarily used for the treatment of major depressive disorders. This combined therapy offers potential benefits for patients experiencing both neuropathic pain and symptoms of depression, providing a comprehensive solution for improved patient outcomes. As with all medications, New Nervijen-NP Tablet should be used under the supervision of a healthcare professional, and potential users should be informed of its potential side effects and contraindications.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
New Nervijen-NP Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
New Nervijen-NP Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
New Nervijen-NP Tablet should be used with caution in patients with kidney disease. Dose adjustment of New Nervijen-NP Tablet may be needed. Please consult your doctor.
Exercise Caution
New Nervijen-NP Tablet may cause side effects which could affect your ability to drive. As New Nervijen-NP Tablet may affect your alertness which may affect your ability to drive.
Consult Doctor
New Nervijen-NP Tablet should be used with caution in patients with liver disease. Dose adjustment of New Nervijen-NP Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for New Nervijen-NP Tablet

Pregabalin (75mg) + Nortriptyline (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their levels in the synaptic cleft and enhancing mood.
Medical applications
The New Nervijen-NP Tablet is a combined pharmaceutical formulation designed for the management of neuropathic pain and depressive disorders. Each tablet contains 75mg Pregabalin and 10mg Nortriptyline. Pregabalin, a gabapentinoid, is effective in relieving neuropathic pain by modulating calcium channels, while Nortriptyline, a tricyclic antidepressant, is primarily used for the treatment of major depressive disorders. This combined therapy offers potential benefits for patients experiencing both neuropathic pain and symptoms of depression, providing a comprehensive solution for improved patient outcomes. As with all medications, New Nervijen-NP Tablet should be used under the supervision of a healthcare professional, and potential users should be informed of its potential side effects and contraindications.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
New Nervijen-NP Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
New Nervijen-NP Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
New Nervijen-NP Tablet should be used with caution in patients with kidney disease. Dose adjustment of New Nervijen-NP Tablet may be needed. Please consult your doctor.
Exercise Caution
New Nervijen-NP Tablet may cause side effects which could affect your ability to drive. As New Nervijen-NP Tablet may affect your alertness which may affect your ability to drive.
Consult Doctor
New Nervijen-NP Tablet should be used with caution in patients with liver disease. Dose adjustment of New Nervijen-NP Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for New Nervijen-NP Tablet















